A Study of Chinese Medicine Treating Depression

NCT ID: NCT02873234

Last Updated: 2016-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

4600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-06-30

Study Completion Date

2020-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chinese Medicine syndrome differentiation has been a prevalent therapy in China for thousands of years. It is based on patients' symptoms, pulse, tongue and coating on the tongue. Therefore, the syndrome of patients and corresponding Traditional Chinese Medicine (TCM) may vary.

This multicenter prospective cohort studies the efficiency and safety of TCM compared with antidepressants. A total number of 4600 cases with primary depression are expected to be collected and divided into 3 cohorts based on the patients' requirement and choices. Patients in one group will receive TCM, and patients in the other two groups will respectively receive antidepressants only and integrated treatment of TCM and antidepressants. This study has 2 phases: treating period and the follow-up.

The main purpose of this long-term study is to evaluate the efficiency of TCM compared with antidepressants in reducing relapse and suicide rate, changing lifestyle, improving patient compliance as well as the safety.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This multicenter prospective cohort uses a modern technique. With its help participants can assess themselves at any time and doctors can supervise patients in case of some adverse events or intervene when patients commit suicide.

The main purpose of this study is to observe the differences between cohorts. However, the intra-group differences are also needed to be evaluated, as the therapies of different participants are various. Therefore, the number of participants treated with each therapy and the time of recovery need to be counted and analyzed. This is a long-term and natural study that participants lost, drug withdrawal and changes in participants'choices of the therapy cannot be avoided. So the reason and number of the previous conditions need to be observed. The safety of TCM and antidepressants is also a considerable outcome which will be evaluated by laboratory examination, Treatment Emergent Symptom Scale (TESS) and the number of participants with adverse events.

Some of the outcomes are measured by questionnaires which can be divided into two parts. One is self-rated assessments including Self-rating Depression Scale (SDS) and Self-reporting Inventory (SCL-90). The other one is evaluated by doctors, such as Hamilton Depression Rating Scale of 24 items (HAMD), Montgomery-Asberg Depression Rating Scale (MADRS), Social Disability Screening Schedule (SDSS), Mini-mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA)and Traditional Chinese Medicine syndrome score.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Traditional Chinese Medicine

Including Zishui Qinggan Yin,Xiaoyao San, Longdan Xiegan Tang, Guipi Decoction, Ningshen Dingzhi Wan, HuangLian-EJiao decoction and Jiaotai Wan.

Traditional Chinese Medicine

Intervention Type DRUG

Participants are treated with TCM twice per day according to syndrome differentiation. For example, the syndrome of one participant with depression is kidney deficiency. He will take Zishui Qinggan Yin twice per day before the breakfast and dinner.

TCM plus antidepressants

This is a integrative therapy that refers to a new treating system including TCM and antidepressants.

Traditional Chinese Medicine

Intervention Type DRUG

Participants are treated with TCM twice per day according to syndrome differentiation. For example, the syndrome of one participant with depression is kidney deficiency. He will take Zishui Qinggan Yin twice per day before the breakfast and dinner.

Antidepressants

Intervention Type DRUG

Participants are treated with different antidepressants. The dosage, frequency and duration are determined according to guideline.

Antidepressants

Antidepressants include Selective serotonin reuptake inhibitors (SSRIs), Norepinephrine-reuptake inhibitors and other antidepressants, such as Paroxetine, Citalopram, Venlafaxine, Sertraline, Trazodone, Maprotiline and so on.

Antidepressants

Intervention Type DRUG

Participants are treated with different antidepressants. The dosage, frequency and duration are determined according to guideline.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Traditional Chinese Medicine

Participants are treated with TCM twice per day according to syndrome differentiation. For example, the syndrome of one participant with depression is kidney deficiency. He will take Zishui Qinggan Yin twice per day before the breakfast and dinner.

Intervention Type DRUG

Antidepressants

Participants are treated with different antidepressants. The dosage, frequency and duration are determined according to guideline.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Chinese Medicine, Chinese Herb Medicine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Subjects meeting all of the following criteria can be included in this study:

* Clinical diagnosis of depression
* The scores of Hamilton Depression scale ( HAMD )≥18
* With stable vital signs, conscious mind and acceptable communication ability
* Can use the mobile phone to do self-evaluation
* Male or female patients between 18 and 65 years old
* Signing the informed consent and agreeing to participate in this study

Exclusion Criteria

Subjects meeting anyone of the following criteria will be excluded from this study:

* Depression caused by other diseases
* Unstable vital signs
* Severe aphasia and agnosia causing disability to communicate
* Alcoholism and other substance dependence
* Diagnosis of other mental disorders except depression
* Serious hepatic or renal insufficiency
* Pregnancy or lactation
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER

Sponsor Role collaborator

Beijing HuiLongGuan Hospital

OTHER

Sponsor Role collaborator

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

First Affiliated Hospital of Heilongjiang Chinese Medicine University

OTHER

Sponsor Role collaborator

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

Shandong University of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

Capital Medical University

OTHER

Sponsor Role collaborator

Xiamen Hospital of Traditional Chinese Medicine

OTHER

Sponsor Role collaborator

Wu Xi Hospital of Traditional Chinese Medicine

UNKNOWN

Sponsor Role collaborator

The Third Affiliated Hospital of Beijing University of Chinese Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qisheng Tang

MD, PHD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Qisheng Tang, MD, PHD

Role: STUDY_DIRECTOR

The Third Affiliated Hospital of Beijing University of Chinese Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Third Affiliated Hospital of Beijing University of Chinese Medicine

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wenjun Sun, MD, PHD

Role: CONTACT

+86 18910259376

Miao Qu, MD, PHD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wenjun Sun, MD, PHD

Role: primary

+86 18910259376

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201507001-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.